Please Wait
Applying Filters...
menu
    • menu
    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    An Enquiry

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Setanaxib

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Calliditas Reports Data On Setanaxib In Alport Syndrome at ASN
    Calliditas Reports Data On Setanaxib In Alport Syndrome at ASN

    11 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/calliditas-therapeutics-reports-safety-data-for-setanaxib-in-patients-with-alport-syndrome-at-the-american-society-of-nephrology-kidney-week-302610714.html

    PR NEWSWIRE
    11 Nov 2025
    Share Share
    Calliditas Provides Setanaxib Patent Update
    Calliditas Provides Setanaxib Patent Update

    18 Jun 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/calliditas-provides-setanaxib-patent-update-302175403.html

    PR NEWSWIRE
    18 Jun 2024
    Share Share
    R&D Day: Setanaxib Anti-Fibrotic Effects, TARPEYO MoA
    R&D Day: Setanaxib Anti-Fibrotic Effects, TARPEYO MoA

    16 May 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/in-person--virtual-rd-day-the-anti-fibrotic-effects-of-setanaxib-and-tarpeyos-mode-of-action-302147989.html

    PR NEWSWIRE
    16 May 2024
    Share Share
    Calliditas announces positive topline results from phase 2 , setanaxib
    Calliditas announces positive topline results from phase 2 , setanaxib

    07 May 2024

    // PHARMABIZ

    https://www.pharmabiz.com/NewsDetails.aspx?aid=168954&sid=2

    PHARMABIZ
    07 May 2024
    Share Share
    Calliditas: Positive Phase 2 Head/Neck Cancer Data For NOX Inhibitor
    Calliditas: Positive Phase 2 Head/Neck Cancer Data For NOX Inhibitor

    06 May 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/calliditas-announces-positive-topline-results-of-phase-2-head-and-neck-cancer-trial-with-lead-nox-inhibitor-candidate-setanaxib-302136510.html

    PR NEWSWIRE
    06 May 2024
    Share Share
    Calliditas’ setanaxib to receive US patent “Use of NOX Inhibitors for Cancer”
    Calliditas’ setanaxib to receive US patent “Use of NOX Inhibitors for Cancer”

    08 Apr 2024

    // PHARMABIZ

    https://www.pharmabiz.com/NewsDetails.aspx?aid=168410&sid=2

    PHARMABIZ
    08 Apr 2024
    Share Share